MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).

BACKGROUND: Monthly application of high-dose intravenous immunoglobulin (IVIG) to patients with secondary progressive multiple sclerosis (MS) showed no clinical benefit in the European Study on Immunoglobulin in MS (ESIMS). Magnetic resonance imaging (MRI) results may provide insights into the morp...

Full description

Bibliographic Details
Main Authors:	Fazekas, F, Sørensen, P, Filippi, M, Ropele, S, Lin, X, Koelmel, H, Fernandez, O, Pozzilli, C, O'Connor, P, Enriquez, M, Hommes, O
Format:	Journal article
Language:	English
Published:	2005

MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).

Similar Items